The effect of dulaglutide on stroke

Background Cardiovascular outcome trials have suggested that glucagon-like peptide 1 (GLP-1) receptor agonists might reduce strokes. We analysed the effect of dulaglutide on stroke within the researching cardiovascular events with a weekly incretin in diabetes (REWIND) trial. Methods REWIND was...

Full description

Saved in:
Bibliographic Details
Institution:Universidad EIA
Main Authors: Gerstein, Hertzel C., Hart, Robert, Colhoun, Helen M., Diaz, Rafael, Lakshmanan, Mark, Botros, Fady T., Probstfield, Jeffrey, Riddle, Matthew C., Rydén, Lars, Messan Atisso, Charles, Dyal, Leanne, Hall, Stephanie, Avezum, Alvaro, Basile, Jan, Conget, Ignacio, Cushman, William C., Hancu, Nicolae, Hanefeld, Markolf, Jansky, Petr, Keltai, Matyas, Lanas, Fernando, Leiter, Lawrence A., Lopez-Jaramillo, Patricio, Cardona Muñoz, Ernesto Germán, Pogosova, Nana, Raubenheimer, Peter J., Shaw, Jonathan E., Sheu, Wayne H-H., Temelkova-Kurktschiev, Theodora, Everest
Format: Artículo de revista
Language:English
Published: Elsevier 2020-02-02
Online Access:https://repositorio.udes.edu.co/handle/001/5715
Tags: Add Tag
No Tags, Be the first to tag this record!